Health Line Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-07-2024
- Paid Up Capital ₹ 3.00 M
as on 16-07-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 28.38%
(FY 2023)
- Profit 3.70%
(FY 2023)
- Ebitda 4.56%
(FY 2023)
- Net Worth 68.94%
(FY 2023)
- Total Assets 15.42%
(FY 2023)
About Health Line Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Imran Nandolia, Manjurahmed Saleh, Raihan Patel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U33110MH2007PTC169349
- Company No.
169349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Health Line Pharmaceuticals Private Limited offer?
Health Line Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, IV Fluids, Dextrose Injection, Pharmaceutical Medicine, Pharmaceutical Products.
Who are the key members and board of directors at Health Line Pharmaceuticals?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjurahmed Saleh  | Additional Director | 02-Nov-2015 | Current |
| Imran Nandolia | Director | 05-Mar-2019 | Current |
| Raihan Patel | Director | 18-Mar-2010 | Current |
| Mustaque Nandolia | Director | 18-Mar-2010 | Current |
| Sadikali Sathiya | Director | 29-Mar-2007 | Current |
| Mehmood Salema | Additional Director | 02-Nov-2015 | Current |
Financial Performance of Health Line Pharmaceuticals.
Health Line Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.38% increase. The company also saw a slight improvement in profitability, with a 3.7% increase in profit. The company's net worth Soared by an impressive increase of 68.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health Line Pharmaceuticals?
In 2022, Health Line Pharmaceuticals had a promoter holding of 7.00% and a public holding of 93.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nandolia Organic Chemicals Private LimitedActive 26 years 11 monthsImran Nandolia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Health Line Pharmaceuticals?
Health Line Pharmaceuticals has a workforce of 40 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health Line Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health Line Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
